FeesSafety
Pluang+

Nationwide recall of blood pressure drug Propranolol over metal contamination risk

Market News
17 Nov 2026, 10:32 WIB
Fox Business
View Source
Bearish
Nationwide recall of blood pressure drug Propranolol over metal contamination risk

Breckenridge Pharmaceutical has issued a nationwide recall of one lot of 60 mg Propranolol Hydrochloride Extended-Release Capsules due to potential metal fragments that could cause internal lacerations. The recalled batch, distributed from October 26 to November 4, may pose risks to soft tissues in the mouth, esophagus, stomach, or intestines. Consumers are advised to stop using the product immediately and consult healthcare providers for replacements. No adverse events have been reported so far, but affected products should be returned to pharmacies and removed from inventories by wholesalers and retailers.

The nationwide recall of a blood pressure drug due to potential metal contamination provides context for health-sector market activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 17, 2026 14:41 WIB: out of 150 priced US health-sector stocks, 37 rose and 109 fell. Notable movers include ALMS (Alumis Inc.) down 9.64% with 100% sell orders, ARWR (Arrowhead Pharmaceuticals Inc.) down 7.47%, and ABEO (Abeona Therapeutics Inc.) up 7.02% with 60% buy orders and a typical hold time of 22 days.

More News

Commit Biologics raises $60M seed round to advance novel immune therapy for cancer and autoimmune diseases

Commit Biologics raises $60M seed round to advance novel immune therapy for cancer and autoimmune diseases

Commit Biologics secured $60 million in seed funding led by Ackermans & van Haaren with participation from AbbVie Ventures, M Ventures, and others. The funds will support clinical development of COM002, a first-in-class immune engager targeting cance...

Company Fundamentals
Bullish
2 hours ago
Dassault Systèmes targets double-digit revenue and EPS growth by 2029, driven by AI and subscription model.

Dassault Systèmes targets double-digit revenue and EPS growth by 2029, driven by AI and subscription model.

Dassault Systèmes announced a new growth cycle aiming for double-digit increases in revenue and diluted EPS by 2029, with revenue expected to exceed €8 billion and EPS €1.80. This growth is supported by a strong subscription model, accelerating adopt...

Company Fundamentals
Bullish
2 hours ago
Dassault Systèmes targets double-digit revenue and EPS growth by 2029 with AI-driven industrial solutions.

Dassault Systèmes targets double-digit revenue and EPS growth by 2029 with AI-driven industrial solutions.

Dassault Systèmes announced at its 2026 Capital Markets Day a new growth cycle aiming for double-digit revenue and EPS growth by 2029, targeting over €8 billion in revenue and €1.80 in non-IFRS diluted EPS. The company highlights its transition to su...

Market News
Bullish
2 hours ago
Trader's 30,000 ETH short position shows $13.68M unrealized gain after opening at $2,283 per token.

Trader's 30,000 ETH short position shows $13.68M unrealized gain after opening at $2,283 per token.

A trader opened a short position of 30,000 Ether (ETH) at about $2,283 per token, with an initial entry value of roughly $68.5 million. As of November 17, this short position showed an unrealized gain of $13.68 million, meaning the profit is on paper...

Market News
Neutral
5 hours ago
MINISO's 9M26 revenue rises 19.3% YoY with strong growth in China and North America, ESG rating upgraded to AAA.

MINISO's 9M26 revenue rises 19.3% YoY with strong growth in China and North America, ESG rating upgraded to AAA.

MINISO Group reported a 19.3% year-on-year revenue increase to RMB18.1 billion for the first nine months of 2026, driven by robust 27.4% growth in Chinese mainland sales and 29.1% growth in North America. The company expanded its store network by 527...

Company Fundamentals
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App